10.03.25 -- Streamline Data Collection, Management, And Compliance

They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.

Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.

Empower personnel by seamlessly capturing and overseeing data, facilitating remote workflows, and eradicating redundant processes with Advarra's eSource + EDC.

Central eSource transforms the conduct of clinical trials by replacing disparate, site-specific source templates with a unified, sponsor-designed framework.

This scalable, participant-centric solution strengthens site efficiency and supports sponsors in executing complex clinical studies with confidence.

Study coordinators aim to enroll participants efficiently through a partnership that leverages direct-to-patient marketing to streamline recruitment.

Managing clinical trial disclosures can be tedious and error-prone, opening the door to noncompliance. TrialScope Disclose provides a better way.

Our centralized platform automates data entry and reporting for Clinicaltrials.gov, CTIS, and more. This reduces manual effort so you can focus on bringing new treatments to patients, not paperwork.

Watch this process video to see how IQVIA’s integrated Interactive Response Technology (IRT) and electronic Clinical Outcome Assessment (eCOA) solution combined with unified platform delivery drives study orchestration and optimization.

Modernize clinical research with a unified digital platform that collects continuous, high-precision data to provide meaningful discovery in clinical trials.

This 11-12 November, Cell 2025 unites 1,000+ experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development. Gain insights across cell culture, therapy development, and CGT manufacturing, and learn from world-renowned leaders Bobby Gaspar (Orchard Therapeutics), Christof Von Kalle, (Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now